1.65

2.37% -0.04

After Hours: 1.73 0.08 +4.85%

Fortress Biotech Inc (FBIO)

Overview News Price History Option Chain Financials Why FBIO Down? Discussions Forecast Stock Split

Fortress Biotech Inc stock is traded at $1.65, with a volume of 154.12K. It is down -2.37% in the last 24 hours and up +13.01% over the past month. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Previous Close:

$1.69

Open:

$1.72

24h Volume:

154.12K

Relative Volume:

0.60

Market Cap:

$52.63M

Revenue:

$80.97M

Net Income/Loss:

$-78.31M

P/E Ratio:

-0.1489

EPS:

-11.0849

Net Cash Flow:

$-129.56M

1W Performance:

-7.30%

1M Performance:

+13.01%

6M Performance:

-2.94%

1Y Performance:

-1.20%

1-Day Range:

$1.62

$1.74

1-Week Range:

$1.62

$1.84

52-Week Range:

$1.325

$2.89

Fortress Biotech Inc Stock (FBIO) Company Profile

Name

Fortress Biotech Inc

Sector

Healthcare (1181)

Industry

Biotechnology (676)

Phone

781-652-4500

Address

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Employee

101

Twitter

@fortressbio

Next Earnings Date

2024-11-12

Latest SEC Filings

FBIO's Discussions on Twitter

Compare FBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FBIO Fortress Biotech Inc	1.65	52.63M	80.97M	-78.31M	-129.56M	-11.08
VRTX Vertex Pharmaceuticals Inc	439.37	128.45B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	575.63	65.17B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	560.90	40.09B	2.58B	1.06B	-1.28B	16.33
ALNY Alnylam Pharmaceuticals Inc	270.19	35.67B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	233.25	27.44B	3.81B	-644.79M	-669.77M	-6.24

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-15-24	Resumed	ROTH MKM	Buy
Aug-04-22	Initiated	Ladenburg Thalmann	Buy
Oct-02-20	Initiated	The Benchmark Company	Buy
Dec-18-19	Initiated	B. Riley FBR	Buy
Feb-28-18	Initiated	B. Riley FBR, Inc.	Buy
Jul-11-17	Initiated	Rodman & Renshaw	Buy
Mar-22-17	Initiated	JMP Securities	Mkt Outperform
Oct-03-16	Initiated	ROTH Capital	Buy

View All

Fortress Biotech Inc Stock (FBIO) Latest News

May 07, 2025

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference | FBIO Stock News - GuruFocus

May 07, 2025

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference - The Manila Times

May 07, 2025

May 05, 2025

Renaissance Technologies LLC Has $356,000 Stock Holdings in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

May 05, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Stock Position Boosted by Envestnet Asset Management Inc. - Defense World

May 05, 2025

May 03, 2025

Geode Capital Management LLC Increases Stock Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

May 03, 2025

Apr 28, 2025

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease - The Globe and Mail

Apr 28, 2025

Apr 22, 2025

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - ADVFN

Apr 22, 2025

Apr 21, 2025

Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN

Apr 21, 2025

Apr 16, 2025

Fortress Biotech Board Member Resigns for New Role - TipRanks

Apr 16, 2025

When the Price of (FBIOP) Talks, People Listen - news.stocktradersdaily.com

Apr 16, 2025

Apr 15, 2025

Fortress Biotech (NASDAQ:FBIOP) Trading Down 2.1% – What’s Next? - Defense World

Apr 15, 2025

Apr 09, 2025

This Fortress Biotech Insider Increased Their Holding By 26% Last Year - Yahoo Finance

Apr 09, 2025

Apr 07, 2025

Roth Capital Forecasts Reduced Earnings for Fortress Biotech - Defense World

Apr 07, 2025

Apr 04, 2025

FBIO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Tuesday Deadline in Securities Class ActionFBIO - MarketScreener

Apr 04, 2025

Apr 01, 2025

SEC Form POS AM filed by Fortress Biotech Inc. - Quantisnow

Apr 01, 2025

Mar 31, 2025

Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 31, 2025

Fortress Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Mar 31, 2025

Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan

Mar 31, 2025

Mar 29, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025

Mar 28, 2025

Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges - TipRanks

Mar 28, 2025

Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan

Mar 28, 2025

MUSTANG BIO, INC. SEC 10-K Report - TradingView

Mar 28, 2025

Journey Medical Reports 2024 Financial Results - TipRanks

Mar 28, 2025

Mar 26, 2025

FDA Green Light for Journey Medical's Rosacea Drug Reshapes 2024 Performance - StockTitan

Mar 26, 2025

Mar 25, 2025